Skip to main content
eScholarship
Open Access Publications from the University of California

ReACT: Overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma.

  • Author(s): Reardon, David A
  • Schuster, James
  • Tran, David Dinh
  • Fink, Karen L
  • Nabors, Louis B
  • Li, Gordon
  • Bota, Daniela Annenelie
  • Lukas, Rimas Vincas
  • Desjardins, Annick
  • Ashby, Lynn Stuart
  • Duic, J Paul
  • Mrugala, Maciej M
  • Werner, Andrea
  • Hawthorne, Thomas
  • He, Yi
  • Green, Jennifer A
  • Yellin, Michael Jay
  • Turner, Christopher D
  • Davis, Thomas A
  • Sampson, John H
  • et al.
Main Content
Current View